1z6p: Difference between revisions

Line 1:

[[Image:1z6p.~~jpg~~|left|200px]]

[[Image:1z6p.png|left|200px]]

<!--

Line 9:

Line 10:

~~'''~~Glycogen phosphorylase AMP site inhibitor complex~~'''~~

===Glycogen phosphorylase AMP site inhibitor complex===

~~==Overview==~~

<!--

~~Inhibition of glycogen phosphorylase (GP) has attracted considerable attention during~~ the ~~last five~~ to ~~10 years~~ as ~~a means of treating the elevated hepatic glucose production seen in patients with type 2 diabetes~~. ~~Several different GP inhibitors binding to various binding sites of the GP enzyme have been reported in the literature~~. ~~In this paper we report on a novel class of compounds that have been identified as potent GP inhibitors. Their synthesis~~, ~~mode of binding to~~ the ~~allosteric AMP site as well as in vitro data on GP inhibition are shown~~. ~~The most potent inhibitor was found to be 4~~-~~[2,4~~-bis-(3-nitrobenzoylamino)phenoxy]phthalic acid (4j) with an IC(50) value of 74 nM. This compound together with a closely related analogue was further characterized by enzyme kinetics and in primary rat hepatocytes.

The line below this paragraph, {{ABSTRACT_PUBMED_15214781}}, adds the Publication Abstract to the page

(as it appears on PubMed at http://www.pubmed.gov), where 15214781 is the PubMed ID number.

-->

==About this Structure==

Line 31:

Line 35:

[[Category: Glycogen phosphorylase b]]

[[Category: Inhibition]]

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on ~~Sat May 3 17~~:14:32 2008''

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 13:13:02 2008''

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 1: / Line 1: @@
-[[Image:1z6p.jpg|left|200px]]
+{{Seed}}
+[[Image:1z6p.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_1z6p|  PDB=1z6p  |  SCENE=  }}
-'''Glycogen phosphorylase AMP site inhibitor complex'''
+===Glycogen phosphorylase AMP site inhibitor complex===
-==Overview==
+<!--
-Inhibition of glycogen phosphorylase (GP) has attracted considerable attention during the last five to 10 years as a means of treating the elevated hepatic glucose production seen in patients with type 2 diabetes. Several different GP inhibitors binding to various binding sites of the GP enzyme have been reported in the literature. In this paper we report on a novel class of compounds that have been identified as potent GP inhibitors. Their synthesis, mode of binding to the allosteric AMP site as well as in vitro data on GP inhibition are shown. The most potent inhibitor was found to be 4-[2,4-bis-(3-nitrobenzoylamino)phenoxy]phthalic acid (4j) with an IC(50) value of 74 nM. This compound together with a closely related analogue was further characterized by enzyme kinetics and in primary rat hepatocytes.
+The line below this paragraph, {{ABSTRACT_PUBMED_15214781}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 15214781 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_15214781}}
 ==About this Structure==
@@ Line 31: / Line 35: @@
 [[Category: Glycogen phosphorylase b]]
 [[Category: Inhibition]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 17:14:32 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 13:13:02 2008''